SECUKINUMAB FOR TREATMENT OF PATIENTS WITH REFRACTORY PSORIASIS
Keyword(s):
Refractory psoriasis with a pronounced negative impact on the quality of life of patients is a high percentage. This disease is a difficult therapeutic task, both from a clinical and scientific point of view that indicates search relevance for new methods of treatment. Convincing data confirming the central role of interleukin-17 in the pathogenesis of psoriasis and the importance of biological therapy aimed at interleukin-17 in the treatment of moderate and severe psoriasis, suggest secukinumab as one of the most promising of the currently existing drugs.
Keyword(s):
Keyword(s):
2021 ◽
Vol 3
(1)
◽
pp. 1087
Keyword(s):
2020 ◽
Vol 3
(7)
◽
pp. 153-164
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 24
(2)
◽
pp. 175-187
◽
Keyword(s):
Pedagogical and learning theories and the improvement and development of lesson and learning studies
2015 ◽
Vol 4
(3)
◽
pp. 186-193
◽
Keyword(s):